# 🔥 EVO2 FOOD VALIDATOR - STRATEGIC OVERVIEW

## **WHAT MAKES US UNIQUE (vs. PubMed/Google Scholar)**

### **Existing Tools (PubMed, Google Scholar, Examine.com):**
- ✅ Find papers and studies
- ✅ Show abstracts and dosing
- ❌ **NO biological plausibility scoring**
- ❌ **NO patient-specific recommendations**
- ❌ **NO mechanism validation**
- ❌ **NO treatment line intelligence**

### **Our Tool (Full Stack):**
- ✅ Find papers (via LLM + PubMed)
- ✅ **Evo2 Biological Plausibility Score** (target → pathway → disease)
- ✅ **S/P/E Integration** (sequence/pathway/evidence fusion)
- ✅ **SAE Features** (line appropriateness, cross-resistance, sequencing fitness)
- ✅ **Biomarker Gating** (HRD+, TP53 status, TMB → personalized verdicts)
- ✅ **MoA Validation** (does compound mechanism align with tumor biology?)
- ✅ **Dynamic Discovery** (works for ANY compound, not hardcoded list)

---

## **🎯 CORE INNOVATION: EVO2 BIOLOGICAL PLAUSIBILITY**

### **The Problem:**
Anyone can search PubMed for "turmeric cancer" and get 50+ papers. But **NO tool can predict IF turmeric will actually work** for a specific patient.

### **Our Solution:**
Use **Evo2's sequence-level understanding** to score:
1. **Baseline:** How active is the target gene in the patient's disease context?
2. **Intervention:** How does the compound modulate that gene?
3. **Delta:** Is the biological impact significant enough to matter?

### **Example: Vitamin D + Ayesha (TP53 R248Q, HRD+)**

**Traditional Search:**
- Found: Multiple RCTs with mixed results
- Evidence Grade: MODERATE
- **Missing:** "But will it work for HER specific mutations?"

**Our Evo2 Analysis:**
```
📊 BIOLOGICAL PLAUSIBILITY ANALYSIS

Target: VDR (Vitamin D Receptor) → TP53 pathway
Disease: Ovarian cancer (TP53 R248Q, HRD+)

Evo2 Scores:
- Baseline: TP53 pathway activity = 0.15 (broken by R248Q)
- Post-Vitamin D: VDR activation → TP53 rescue = 0.35
- Delta: +0.20 (MODERATE plausibility)

Verdict: "May partially restore p53 function via VDR"
Overall Score: 0.52 (WEAK_SUPPORT)
Confidence: 0.68 (MODERATE-HIGH due to HRD+ biomarker match)
```

**This is IMPOSSIBLE with just literature search!**

---

## **🏗️ ARCHITECTURE OVERVIEW**

```
User Query: "Can Vitamin D help my ovarian cancer?"
    ↓
[1] Dynamic Target Extraction
    → Check food_targets.json
    → Query ChEMBL (if not found)
    → Extract from PubMed literature (LLM)
    → Result: ["VDR", "TP53"]
    ↓
[2] Evo2 Biological Plausibility (if use_evo2=True)
    → Fetch VDR gene sequence
    → Score baseline disease-active state
    → Score post-Vitamin D intervention
    → Compute delta = plausibility score
    → Result: overall_plausibility = 0.45, verdict = "MODERATE"
    ↓
[3] S/P/E Integration
    → Sequence (S): Evo2 plausibility (0.45)
    → Pathway (P): VDR signaling aligns with DNA repair (0.85)
    → Evidence (E): Literature grade = "MODERATE" (0.60)
    → Aggregate: overall_score = 0.61
    ↓
[4] SAE Treatment Line Features (if treatment_history provided)
    → Line appropriateness: 1.0 (perfect for L3 post-platinum)
    → Cross-resistance: 0.0 (no overlap with prior therapies)
    → Sequencing fitness: 0.9 (supports next-line chemo)
    ↓
[5] Confidence Modulation
    → Base: 0.60 (S/P/E average)
    → Evo2 boost: +0.10 (HIGH plausibility targets)
    → SAE boost: +0.05 (high line appropriateness)
    → Biomarker boost: +0.05 (HRD+ → DNA repair pathway match)
    → Final: 0.80 (HIGH confidence)
    ↓
[6] LLM Literature Enhancement (if use_llm=True)
    → Search PubMed: "Vitamin D AND ovarian cancer"
    → Extract papers, synthesize evidence
    → Result: 15 papers, confidence boost +0.15
    ↓
[7] Verdict Classification
    → overall_score: 0.61, confidence: 0.80
    → Verdict: "SUPPORTED" (score ≥0.65 AND confidence ≥0.70)
    → Recommendation: "✅ RECOMMENDED: Strong biological plausibility..."
```

---

## **📦 COMPONENT BREAKDOWN**

### **Backend Services:**
1. **`evo2_food_plausibility.py`** - Evo2 biological plausibility scoring
2. **`food_spe_integration.py`** - S/P/E + SAE aggregation
3. **`compound_target_extraction.py`** - Dynamic target discovery

### **API Endpoints:**
- `POST /api/hypothesis/validate_food_complete` - Main validation endpoint

### **Frontend Components:**
- `FoodValidatorAB.jsx` - Enhanced with Evo2 + S/P/E + SAE display
- `AyeshaTwinDemo.jsx` - Updated to test ALL compounds

---

## **🎯 VALUE PROPOSITION**

**For Ayesha (and any patient):**
- "Will this compound actually work for ME?" (not just "does literature say it might work?")
- Patient-specific recommendations based on mutations, biomarkers, treatment history
- Timing optimization: "When should I take this in my treatment sequence?"

**For Research/Clinical Use:**
- Mechanistic validation beyond literature
- Biomarker-aware recommendations
- Treatment line intelligence (SAE features)
- Transparent provenance (full audit trail)

---

## **⚔️ DIFFERENTIATION SUMMARY**

| Feature | PubMed/Google Scholar | Our Tool |
|---------|----------------------|----------|
| Literature Search | ✅ | ✅ |
| Evidence Synthesis | ❌ | ✅ (LLM) |
| Biological Plausibility | ❌ | ✅ (Evo2) |
| Patient-Specific | ❌ | ✅ (mutations/biomarkers) |
| Treatment Line Intelligence | ❌ | ✅ (SAE features) |
| Works for ANY Compound | ❌ | ✅ (dynamic extraction) |
| S/P/E Integration | ❌ | ✅ |
| Confidence Modulation | ❌ | ✅ (multi-stage) |

**Result:** The ONLY tool that can **predict IF a compound will work**, not just what the literature says.

---

**Next Steps:** See [`phases/PHASE1_EVO2_PLAUSIBILITY.md`](./phases/PHASE1_EVO2_PLAUSIBILITY.md) to start building.

